Capital Directions Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Capital Directions Investment Advisors, LLC

$268 Million
Q4 2022

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $1,904 - $2,145	-33 Reduced 13.04%	220 $14,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $14,653 - $18,362	253 New	253 $15,000
Q4 2021 Feb 22, 2022	SELL	$64.88 - $73.64 $79,153 - $89,840	-1,220 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $77,433 - $84,607	1,220 New	1,220 $84,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $60,000 - $68,460	-1,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $62,100 - $78,080	1,000 New	1,000 $63,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $72,340 - $84,000	-1,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $62,510 - $69,000	1,000 New	1,000 $63,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $71,280 - $78,920	-1,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $64,879 - $75,680	1,000 New	1,000 $71,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Directions Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Directions Investment Advisors, LLC with notifications on news.

Account